Treatment Guided by LaSara Physicians
Vasoactive Intestinal Peptide (VIP) Nasal Spray – The Sister Peptide to BPC-157
Unlock the Power of VIP for Inflammation, Immunity, and Hormonal Balance
Vasoactive Intestinal Peptide (VIP) is a naturally occurring 28-amino acid peptide known for its powerful role in immune modulation, inflammation control, and endocrine regulation. Often referred to as the sister peptide to BPC-157, VIP is essential for maintaining homeostasis throughout the body. Produced in key areas such as the gastrointestinal tract and central nervous system, VIP supports immune balance, neurological health, respiratory function, and hormonal regulation—making it a versatile treatment option for various health concerns.
This product works best with consistent use.
When combined with a healthy diet, most users see peak results at 8–12 weeks. Subscribe to stay on track.
- ✔ Regulates the immune response by suppressing pro-inflammatory cytokines, potentially benefiting autoimmune and inflammatory conditions.
- ✔ Supports nerve regeneration and protects neurons, showing potential in reversing grey matter nuclear atrophy seen in Chronic Inflammatory Response Syndrome (CIRS).
- ✔ Enhances airway relaxation and oxygenation, making it useful for asthma, pulmonary hypertension, and other respiratory conditions.
- ✔ Normalizes gut motility and secretion, helping conditions like gastroparesis and inflammatory bowel disorders.
- ✔ Helps regulate estradiol, testosterone, and T-regulatory cell function, supporting overall endocrine health.
- ✔ Reduces inflammation to alleviate pain and discomfort in chronic inflammatory diseases.
- ✔ Enhances insulin sensitivity and receptor activity, aiding in metabolic health and glucose control.
Frequently Asked Questions
Complete Your Protocol
Our physicians have curated a selection of treatments that complement Vasoactive Intestinal Peptide (VIP) Nasal Spray – The Sister Peptide to BPC-157's benefits — each clinically selected to support your goals at every stage of the journey.
SEE ALL
